TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06221332

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: % 0.25 bupivakain 20cc
Description: Pregnant women in group S will be given 0.25% bupivacaine, 10 cc on each side.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 20 cc saline
Description: Pregnant women in Group K will be given 10 cc of saline on both sides.
Study: NCT06212154

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: Participants will receive ThisCART19A cell infusion after preconditioning, and they need to be closely monitored for 28 days following CAR-T cell infusion.
Study: NCT06137846

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Air-Polish
Description: Dental implant will be cleaned with an airpolishing device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air-Polish
Description: Dental implant will be cleaned with an airpolishing device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasonic
Description: Dental implant will be cleaned with an ultrasonic device with a plastic tip
Study: NCT05700539

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy
Description: A ten-week treatment based on cognitive behavioral therapy for ADHD, including two mandatory modules and at least four self-selected modules (out of ten available modules). The treatment consists of reading material and exercises to be completed each week.
Study: NCT06063356

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular and extra-articular Dextrose Prolotherapy injection
Description: In the prolotherapy group, 28 patients will receive intra-articular 5 cc 25% dextrose solution (4 cc 30% dextrose + 1 cc saline) and extra-articular 10 cc 15% dextrose solution (5 cc 30% dextrose + 2.5 cc saline + 2.5 cc 1% lidocaine) in 3 sessions.Extra-articular Injection: Using a sterile syringe with a 27 gauge needle tip (Dental), the points previously found and marked with US (medial collateral ligament, lateral collateral ligament, patellar ligament and adhesion sites of coronary ligaments; pes anserine and superior patellar regions) perpendicular to the surface, using peppering technique, a total of 10 cc of 15% dextrose solution (5 cc 30% dextrose + 2.5 cc saline + 2.5 cc 1% lidocaine) will be injected in small volumes (0.5cc-1cc) at each point.Injection applications will be done at weeks 0 - 3 - 6.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular and extra-articular Dextrose Prolotherapy injection
Description: In the prolotherapy group, 28 patients will receive intra-articular 5 cc 25% dextrose solution (4 cc 30% dextrose + 1 cc saline) and extra-articular 10 cc 15% dextrose solution (5 cc 30% dextrose + 2.5 cc saline + 2.5 cc 1% lidocaine) in 3 sessions.Extra-articular Injection: Using a sterile syringe with a 27 gauge needle tip (Dental), the points previously found and marked with US (medial collateral ligament, lateral collateral ligament, patellar ligament and adhesion sites of coronary ligaments; pes anserine and superior patellar regions) perpendicular to the surface, using peppering technique, a total of 10 cc of 15% dextrose solution (5 cc 30% dextrose + 2.5 cc saline + 2.5 cc 1% lidocaine) will be injected in small volumes (0.5cc-1cc) at each point.Injection applications will be done at weeks 0 - 3 - 6.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular and extra-articular Saline injection
Description: In the saline group, 28 patients are planned to receive 3 sessions of intra-articular 5 cc saline and extra-articular 10 cc lidocaine-serum physiologic solution (5 cc saline + 5 cc 1% lidocaine).Injection applications will be done at weeks 0 - 3 - 6.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular and extra-articular Saline injection
Description: In the saline group, 28 patients are planned to receive 3 sessions of intra-articular 5 cc saline and extra-articular 10 cc lidocaine-serum physiologic solution (5 cc saline + 5 cc 1% lidocaine).Injection applications will be done at weeks 0 - 3 - 6.
Study: NCT05298111

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Formulation 3
Description: Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Study: NCT06536153

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Amaranth grain flat bread
Description: The recipe will be produced according to the recommended dietary allowance (RDA); based on RDA, 200 g of flat-bread (30% chickpea and 70% amaranth grain) comprised 30 mg of iron, which can satisfy 50% of RDA supposing 15-20% iron absorption (54). A prior study concluded that the acceptability was satisfactory in the community (55). Also, a study from the Hawassa University Department of Food Sciences reported that amaranth-grain flat-bread was safe for consumption for 48 hours after preparation and improved the nutritional values (56). To lower the phytate levels in the amaranth grain, home-level processing will be used. For 24 hours, amaranth grain will be soaked in water with 5 milliliters of lemon juice per 100 milliliters of water, and it will germinate for 72 hours. It will be sun-dried, roasted, and ground using a nearby electrical mill before fermented bread is made

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Amaranth grain flat bread
Description: The recipe will be produced according to the recommended dietary allowance (RDA); based on RDA, 200 g of flat-bread (30% chickpea and 70% amaranth grain) comprised 30 mg of iron, which can satisfy 50% of RDA supposing 15-20% iron absorption (54). A prior study concluded that the acceptability was satisfactory in the community (55). Also, a study from the Hawassa University Department of Food Sciences reported that amaranth-grain flat-bread was safe for consumption for 48 hours after preparation and improved the nutritional values (56). To lower the phytate levels in the amaranth grain, home-level processing will be used. For 24 hours, amaranth grain will be soaked in water with 5 milliliters of lemon juice per 100 milliliters of water, and it will germinate for 72 hours. It will be sun-dried, roasted, and ground using a nearby electrical mill before fermented bread is made
Study: NCT05560841

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: topical treatment
Description: Topical application of Nailner brush 2in1 for toenail onychomycosis
Study: NCT06197945

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan bent leg raise
Description: Mulligan bent leg raise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan bent leg raise with Bowen therapy
Description: Mulligan bent leg raise with Bowen therapy
Study: NCT06165484

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laparoscopy and hysteroscopy
Description: laparoscopy and hysteroscopy for patient with failed IVF
Study: NCT05635552

Intervention type: DIAGNOSTIC_TEST
Intervention: Dynamic retinal vessel analysis (DVA)
Description: DVA is an established, non-invasive tool to measure the responsiveness of retinal vessels to flickering light. In addition static retinal vessel parameters are recorded.

Intervention type: DIAGNOSTIC_TEST
Intervention: Dynamic retinal vessel analysis (DVA)
Description: DVA is an established, non-invasive tool to measure the responsiveness of retinal vessels to flickering light. In addition static retinal vessel parameters are recorded.

Intervention type: DIAGNOSTIC_TEST
Intervention: Dynamic retinal vessel analysis (DVA)
Description: DVA is an established, non-invasive tool to measure the responsiveness of retinal vessels to flickering light. In addition static retinal vessel parameters are recorded.

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: OCT is an imaging technique which applies low-coherence light to capture high resolution images from the ocular fundus.

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: OCT is an imaging technique which applies low-coherence light to capture high resolution images from the ocular fundus.
Study: NCT05402787

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual visit
Description: A virtual visit will be made to mothers whose babies are hospitalized in the neonatal intensive care unit
Study: NCT05494086

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DPLDG
Description: Dual-port laparoscopic distal gastrectomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LDG
Description: Laparoscopic distal gastrectomy
Study: NCT05635552

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: OCT is an imaging technique which applies low-coherence light to capture high resolution images from the ocular fundus.

Intervention type: DIAGNOSTIC_TEST
Intervention: Biochemistry and immune phenotyping
Description: Blood sample collection for clinical chemistry and isolation of PBMCs for FACS analysis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Biochemistry and immune phenotyping
Description: Blood sample collection for clinical chemistry and isolation of PBMCs for FACS analysis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Biochemistry and immune phenotyping
Description: Blood sample collection for clinical chemistry and isolation of PBMCs for FACS analysis.
Study: NCT05537376

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SUicide Prevention by Peers Offering Recovery Tactics
Description: Following the completion of a comprehensive mental health evaluation by a licensed VA provider, which includes a suicide safety plan, if a Veteran is having active thoughts of suicide or made a suicide attempt in past three months, they may be eligible for SUPPORT. In SUPPORT, the Peer Specialist and Veteran co-create a personalized suicide-focused recovery plan (SUPPORT Plan) in flexible, 50-minute weekly encounters. The SUPPORT Plan includes modules that focus on valuing recovery, building a hope kit and daily plan, setting recovery goals, and looking ahead to enhance the Veteran's safety plan. Learning strategies are incorporated into each module to promote salience and recall of intervention material. The Peer Specialist works closely with the Veteran's treatment team and uses the most recent safety plan in the Veteran's chart to help complete the SUPPORT Plan as well as reinforce the usage of the Veteran's safety plan.
Study: NCT04805762

Intervention type: OTHER
Intervention: Your COACH Next Door
Description: Children in the study are attending the lifestyle intervention Your COACH Next Door. A coach is supporting the child and it's family to reach their goals regarding lifestyle.
Study: NCT04736082

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group: Infant Formula with hydrolyzed protein
Description: Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (intervention formula manufactured from extensively hydrolysed whey protein).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group: Infant Formula with intact protein
Description: Infants will receive infant formula during the first 120 days of life with optional follow up until 180 days of life (control formula manufactured from intact cow's milk protein).
Study: NCT05235087

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bovine atelocollagen intradermal injection
Description: Intradermal skin test injection
Study: NCT05458934

Intervention type: OTHER
Intervention: No intervention
Description: no intervention

Intervention type: OTHER
Intervention: No intervention
Description: no intervention
Study: NCT05128318

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nissen Fundoplication, cholecystectomy
Description: Collection of adipose tissue pieces in the context of programmed abdominal surgery to treat to treat hiatal hernia, gastroesophageal reflux or vesicular lithiasis. During the surgery treatment, adipose tissue of 1-2 cm3 will be collected for the protocol by laparoscopy by the surgeon in charge of the procedures.
Study: NCT05642767

Intervention type: DIAGNOSTIC_TEST
Intervention: culture on cetrimide agar
Description: Samples will be inoculated on cetrimide agar using the plating out technique.

Intervention type: DIAGNOSTIC_TEST
Intervention: culture on cetrimide agar
Description: Samples will be inoculated on cetrimide agar using the plating out technique.

Intervention type: DIAGNOSTIC_TEST
Intervention: Staining with Gram stain
Description: colonies on cetrimide agar will be spread on glass slide and stained by gram stain

Intervention type: DIAGNOSTIC_TEST
Intervention: Staining with Gram stain
Description: colonies on cetrimide agar will be spread on glass slide and stained by gram stain

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibiotic sensitivity testing
Description: Antibiotic sensitivity testing will be done by disc diffusion method according to CLSI

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibiotic sensitivity testing
Description: Antibiotic sensitivity testing will be done by disc diffusion method according to CLSI

Intervention type: DIAGNOSTIC_TEST
Intervention: Molecular detection to efflux genes and some virulence genes
Description: Molecular detection to efflux genes and some virulence genes by conventional PCR
Study: NCT05274477

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fampridine SR
Description: Fampridine SR is an inhibitor of voltage gated potassium channels and is approved in Switzerland for treatment of gait problems in patients with Multiple Sclerosis (MS).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: no active component
Study: NCT06153264

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neurodynamic mobilization exercise
Description: Upper extremity neurodynamic mobilization exercises and upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strengthening exercises
Description: upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strengthening exercises
Description: upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks
Study: NCT05646095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bolstering Sleep and Adjustment in Foster Environments (B-SAFE)
Description: We will adapt CBT for insomnia for children in foster care using a trauma-informed approach that considers the child's individual history, unique family environment, and child welfare policies regarding safe sleep practices.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Bolstering Sleep and Adjustment in Foster Environments (B-SAFE)
Description: We will adapt CBT for insomnia for children in foster care using a trauma-informed approach that considers the child's individual history, unique family environment, and child welfare policies regarding safe sleep practices.
Study: NCT04862780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration
Study: NCT05635552

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength test
Description: Measure the maximum isometric strength of the hand and forearm muscles and their fatiguability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength test
Description: Measure the maximum isometric strength of the hand and forearm muscles and their fatiguability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires (Patient reported outcomes)
Description: The questionnaires evaluate anxiety, depression, chronic fatigue, quality of life, and post-covid typical symptoms

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires (Patient reported outcomes)
Description: The questionnaires evaluate anxiety, depression, chronic fatigue, quality of life, and post-covid typical symptoms
Study: NCT04862780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration
Study: NCT05667155

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CB dualCAR-NK19/70
Description: Lentiviral vector-transducted cord blood-derived NK cells to express anti-CD19/CD70 CAR and IL15
Study: NCT04862780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-945
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osimertinib
Description: Osimertinib tablets for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osimertinib
Description: Osimertinib tablets for oral administration
Study: NCT05507463

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KBP-7072
Description: KBP-7072

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05358197

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: yoga
Description: laughter yoga
Study: NCT05356923

Intervention type: RADIATION
Intervention: 68Gallium FAPI PET/MR scan
Description: 68Gallium FAPI PET/MR scan
Study: NCT06065267

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sequential
Description: amoxicillin 1000 mg bid ,esomprazole 20 bid for one week then levofloxacine 500 mg q.d, metraonidazoel 500 500 bid, and esomprazole 20 bid for one week

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levofloxacin 500Mg Oral Tablet
Description: Levofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid
Study: NCT06210191

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intramedullary headless screw fixation
Description: fixation of fractures of metacarpals and phalanges by intramedullary headless screws
Study: NCT05837585

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air quality sensors
Description: The air quality sensors detect air quality, including temperature, humidity, carbon dioxide, respirable suspended particulates (PM10 or PM2.5), total volatile organic compounds (TVOC) and formaldehyde (HCHO), which may influence health of residences. The managers of the service unit will decide the changes of activities to improve air quality and long-term measures based on the detected air quality indexes. The care staff will follow these decisions.
Study: NCT04903678

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Melphalan is performed for intrathecal chemotherapy
Study: NCT05311280

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high intensity interval training plus myotherapy
Description: High intensity interval training (HIIT) has been proved its same effect on lower down body fat as moderate intensity continuous training (MICT). In addition, HIIT has the additional benefit of being a time-efficient program which can increase exercise adherence and the participants were more likely to intend to continue. Previous two studies show that HIIT could improve the severity of OSA in both obese adults and obese children.~Myotherapy: MT is composed of isotonic and isometric exercise related to oral, oropharyngeal, and respiratory exercise. Based on previous review and meta-analysis, MT can decrease not only AHI score, but also ESS score. It means that MT is beneficial to release the symptom of sudden apnea and hypopneas.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: home exercise plus myotherapy
Description: Home exercise: ambulation by patients themselves Myotherapy: MT is composed of isotonic and isometric exercise related to oral, oropharyngeal, and respiratory exercise. Based on previous review and meta-analysis, MT can decrease not only AHI score, but also ESS score. It means that MT is beneficial to release the symptom of sudden apnea and hypopneas.
Study: NCT05320770

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US guided TMJ intra articular injection
Description: therapeutic TMJ intra articulatr injection of blood under sonography guidance to reduce joint hyper mobility
Study: NCT05894278

Intervention type: OTHER
Intervention: Prescription data collection
Description: Prescription data collection

Intervention type: OTHER
Intervention: Prescription data collection
Description: Prescription data collection

Intervention type: OTHER
Intervention: Prescription data collection
Description: Prescription data collection
Study: NCT05356923

Intervention type: RADIATION
Intervention: 68Gallium FAPI PET/MR scan
Description: 68Gallium FAPI PET/MR scan

Intervention type: RADIATION
Intervention: 68Gallium FAPI PET/MR scan
Description: 68Gallium FAPI PET/MR scan